ResearcherMonash Medical CentreActive in the last 2 years
Owen McKay
Matched on ORCID iD 0000-0001-8280-216X; OpenAlex author ID A5049137048. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 3
- Endoscopic ultrasound molecular evaluation of pancreatic cancer trial to profile molecular landscape of inoperable pancreatic ductal adenocarcinoma. Co-author DOI 10.1055/a-2733-1068↗
- Case Report: Two cases of long-term survival in advanced pancreatic cancer patients following treatment with KRAS G12C inhibitors. First author DOI 10.3389/fonc.2025.1691760↗
- Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High Tumor Mutation Burden: Case Report and L… First author DOI 10.1200/po.21.00437↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daniel Gerald Croagh · 3 shared papers, 2022–2026 · strength 0.79
- Paper Case Report: Two cases of long-term survival in advanced pancreatic cancer patients following treatment with KRAS G12C … DOI 10.3389/fonc.2025.1691760↗
- Paper Endoscopic ultrasound molecular evaluation of pancreatic cancer trial to profile molecular landscape of inoperable panc… DOI 10.1055/a-2733-1068↗
- Paper Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High … DOI 10.1200/po.21.00437↗
- Vinod Ganju · 2 shared papers, 2022–2025 · strength 0.55
- Paper Case Report: Two cases of long-term survival in advanced pancreatic cancer patients following treatment with KRAS G12C … DOI 10.3389/fonc.2025.1691760↗
- Paper Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High … DOI 10.1200/po.21.00437↗
- Joanne Lundy · 2 shared papers, 2022–2026 · strength 0.46
- Paper Endoscopic ultrasound molecular evaluation of pancreatic cancer trial to profile molecular landscape of inoperable panc… DOI 10.1055/a-2733-1068↗
- Paper Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High … DOI 10.1200/po.21.00437↗
- Saeed Aslani · 1 shared paper, 2025 · strength 0.33
- John Raymond Zalcberg · 1 shared paper, 2026 · strength 0.23
- Sean Michael Grimmond · 1 shared paper, 2026 · strength 0.23
- Belinda Lee · 1 shared paper, 2026 · strength 0.23
- Manoop S. Bhutani · 1 shared paper, 2026 · strength 0.23
- Brendan John Jenkins · 1 shared paper, 2026 · strength 0.23
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.